Post-partum hemorrhage (PPH), defined as blood loss after vaginal or cesarean delivery, is the leading cause of maternal deaths especially in developing and under developed countries. PPH is categorized as primary PPH if blood loss occurs within 24 hours of delivery and secondary PPH if the blood loss occurs after 24 hours of delivery. Poor uterine conditions, which include, failure of uterus to contract after childbirth is primarily the reason for post-partum hemorrhage and thus the demand for modern PPH treatment devices outpace the traditional methods as these devices aim towards healing the uterine conditions and problems of uterus contractions.... Research Beam Model: Research Beam Product ID: 925265 5370 USD New
Post-partum Hemorrhage (PPH) Devices Market by type (Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and Uterine balloon tamponade) - Global Opportunity Analysis and Industry Forecast, 2014-2022
 
 

Post-partum Hemorrhage (PPH) Devices Market by type (Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and Uterine balloon tamponade) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Category : Medical Devices
  • Published On : September   2016
  • Pages : 105
  • Publisher : Allied Market Research
 
 
 

Post-partum hemorrhage (PPH), defined as blood loss after vaginal or cesarean delivery, is the leading cause of maternal deaths especially in developing and under developed countries. PPH is categorized as primary PPH if blood loss occurs within 24 hours of delivery and secondary PPH if the blood loss occurs after 24 hours of delivery. Poor uterine conditions, which include, failure of uterus to contract after childbirth is primarily the reason for post-partum hemorrhage and thus the demand for modern PPH treatment devices outpace the traditional methods as these devices aim towards healing the uterine conditions and problems of uterus contractions.

The growth of post-partum hemorrhage devices market is supported by a number of factors such as rise in incidence of PPH cases, increase in awareness regarding PPH risk factors, and increased pregnancy related complications. Moreover, increase in number of education and training initiatives by the government on PPH has also propelled the growth of this market. However, lack of awareness in developing countries about the available devices and low adoption of PPH devices in these countries are expected to restrain the growth of the market.

The report segments the post-partum hemorrhage devices market on the basis of product type and geography. According to the product type, the market is segmented into Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and uterine balloon tamponade. Uterine balloon tamponade is further segmented into Foley catheter Condom catheter, Bakri balloon tamponade, Rusch balloon and BT-Cath balloon. Geographical breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

Over the past few years, the key players have adopted product development (including product launches, approvals, and clinical trials) as their key developmental strategy. For instance, in July 2015, Inpress technologies completed and announced the successful completion of its first human trial for the device to control post-partum hemorrhage. The trial was conducted on 10 patients to evaluate the efficiency of the device in controlling postpartum hemorrhage. The study generated significant results as the device on implantation into uterus was able to initiate hemorrhage control response within two minutes and attained full control on hemorrhage in just two hours on average.

The key companies that operate in the world post-partum hemorrhage devices market include

  • Utah Medical Products, Inc.
  • C. R. Bard, Inc.
  • Cook Medical, Inc.
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • Bactiguard AB
  • Program for Appropriate Technology in Health (PATH)
  • 3RD Stone Design, Inc.
  • Vitality Medical
  • Revmedx Inc.

 KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the world post-partum hemorrhage devices market
  • Geographically, the market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA
  • This study evaluates competitive landscape to predict the competitive environment across the geographies
  • This report entails the detailed quantitative analysis of the current market and estimations through 2014–2022, which assists to identify the prevailing opportunities
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided
  • Region-wise and country-wise post-partum hemorrhage devices market conditions are comprehensively analyzed in this report

KEY MARKET SEGMENTS:

By Product Type

  • Non-Pneumatic Anti-Shock Garment
  • Uniject Prefilled Injection System
  • Uterine Balloon Tamponade
    • Foley Catheter
    • Condom Catheter
    • Bakri balloon tamponade
    • BT-Cath balloon
    • Rusch balloon

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Russia
    • U.K.
    • Germany
    • Italy
    • Spain
    • Netherlands
    • Ukraine
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Indonesia
    • Rest of APAC
  • LAMEA
    • Brazil
    • UAE
    • Nigeria
    • Turkey
    • South Africa
    • Saudi Arabia
    • Argentina
    • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Research methodology

1.2.1 Secondary Research
1.2.2 Primary research
1.2.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets

3.3 Porters Five Forces Analysis
3.4 Market Dynamics

3.4.1 Drivers

3.4.1.1 Support from healthcare organizations
3.4.1.2 Rising pregnancy complications
3.4.1.3 Technological advancements

3.4.2 Restraints

3.4.2.1 Dearth of trained healthcare providers
3.4.2.2 High cost of the devices

3.4.3 Opportunities

3.4.3.1 Drugs failure

3.5 Clinical Trials
3.6 Government Guidelines and Recommendations

CHAPTER 4 WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Non pneumatic anti-shock garment (NASG)

4.2.1 Key market trends
4.2.2 Growth factors and opportunities
4.2.3 Market size and forecast

4.3 Uniject prefilled injection system

4.3.1 Key market trends
4.3.2 Growth factors and opportunities
4.3.3 Market size and forecast

4.4 Uterine balloon tamponade

4.4.1 Key market trends
4.4.2 Growth factors and opportunities
4.4.3 Market size and forecast

4.4.3.1 Foley catheter
4.4.3.2 Market size and forecast
4.4.3.3 Condom catheter
4.4.3.4 Market size and forecast
4.4.3.5 Bakri balloon tamponade
4.4.3.6 Market size and forecast
4.4.3.7 Rusch balloon
4.4.3.8 Market size and forecast
4.4.3.9 BT-Cath balloon
4.4.3.10 Market size and forecast

CHAPTER 5 WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET, BY GEOGRAPHICAL PRESENCE

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S. market size and forecast
5.2.5 Canada market size and forecast
5.2.6 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany market size and forecast
5.3.5 France market size and forecast
5.3.6 U.K. market size and forecast
5.3.7 Italy market size and forecast
5.3.8 Netherlands market size and forecast
5.3.9 Ukraine market size and forecast
5.3.10 Spain market size and forecast
5.3.11 Rest of Europe market size and forecast

5.4 Asia Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Japan market size and forecast
5.4.5 China market size and forecast
5.4.6 India market size and forecast
5.4.7 Australia market size and forecast
5.4.8 South Korea market size and forecast
5.4.9 Indonesia market size and forecast
5.4.10 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil market size and forecast
5.5.5 Nigeria market size and forecast
5.5.6 Turkey market size and forecast
5.5.7 Saudi Arabia market size and forecast
5.5.8 South Africa market size and forecast
5.5.9 Argentina market size and forecast
5.5.10 Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Utah Medical Products Inc.

6.1.1 Company overview
6.1.2 Operating business segments
6.1.3 Business performance

6.2 C. R. Bard, Inc.

6.2.1 Company Overview
6.2.2 Operating Business Segments
6.2.3 Business Performance
6.2.4 Key Strategic Moves & Developments

6.3 Cook Medical, Inc.

6.3.1 Company overview

6.4 Becton Dickinson and Company (Carefusion Corp.)

6.4.1 Company overview
6.4.2 Business performance

6.5 Teleflex Incorporated

6.5.1 Company overview
6.5.2 Operating business segments
6.5.3 Business performance

6.6 Bactiguard AB

6.6.1 Company overview
6.6.2 Operating business segments
6.6.3 Business performance
6.6.4 Key strategic moves & developments

6.7 Program for Appropriate Technology in Health (PATH)

6.7.1 Company overview
6.7.2 Operating business segments
6.7.3 Business performance

6.8 3RD Stone Design Inc.

6.8.1 Company overview
6.8.2 Operating business segments

6.9 ZOEX NIASG

6.9.1 Company overview

6.10 Inpress technologies

6.10.1 Company overview

*Other vendors considered in this market include Vitality Medical and RevMedx, Inc.

List of Figures

FIG. 1 PPH DEVICES MARKET, BY PRODUCT
FIG. 2 PPH DEVICES MARKET, BY REGION
FIG. 3 CAUSES OF MATERNAL DEATHS
FIG. 4 MATERNAL MORATLITY RATE, BY COUNTRY, 2015
FIG. 5 MATERNAL MORTALITY RATE, BY REGION, 2015
FIG. 6 CAUSES OF PPH, 2012, (%)
FIG. 7 TOP INVESTMENT POCKETS IN THE WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET
FIG. 8 PORTERS FIVE FORCES ANALYSIS
FIG. 9 TOP IMPACTING FACTORS: POSTPARTUM HEMORRAHGE DEVICES MARKET
FIG. 10 LIST OF CLINICAL TRIALS
FIG. 11 CLINICAL TRIALS, BY STATUS
FIG. 12 CLINICAL TRIALS, BY REGION
FIG. 13 NON PNEUMATIC ANTI SHOCK GARMENT (NASG): POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 14 UNIJECT PREFILLED INJECTION SYSTEM: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 15 UTERINE BALLOON TAMPONADE: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 16 FOLEY CATHETER: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 17 CONDOM CATHETER: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 18 BAKRI BALLOON TAMPONADE: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 19 RUSCH BALLOON: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 20 BT-CATH: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 21 NORTH AMERICA: MATERNAL MORATLITY RATE, BY COUNTRY, 2015
FIG. 22 U.S.: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 23 CANADA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 24 MEXICO: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 25 EUROPE: MATERNAL MORATLITY RATIOS, BY COUNTRY, 2015
FIG. 26 GERMANY: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 27 FRANCE: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 28 U.K.: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 29 ITALY: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 30 NETHERLANDS: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 31 UKRAINE: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 32 SPAIN: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 33 REST OF EUROPE: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 34 ASIA-PACIFIC: MATERNAL MORATLITY RATIOS, BY COUNTRY, 2015
FIG. 35 JAPAN: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 36 CHINA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 37 INDIA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 38 AUSTRALIA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 39 SOUTH KOREA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 40 INDONESIA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 41 REST OF ASIA-PACIFIC: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 42 LAMEA: MATERNAL MORATLITY RATIOS, BY COUNTRY, 2015
FIG. 43 BRAZIL: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 44 NIGERIA.: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 45 TURKEY: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 46 SAUDI ARABIA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 47 SOUTH AFRICA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 48 ARGENTINA: POSTPARTUM HEMORRHAGE DEVICES MARKET , 20142022 ($MILLION)
FIG. 49 REST OF LAMEA: POSTPARTUM HEMORRHAGE DEVICES MARKET, 20142022 ($MILLION)
FIG. 50 UTMD-NET SALES, 2013-2015, ($MILLION)
FIG. 51 UTMD-NET SALES, BY SEGMENTS, 2015 (%)
FIG. 52 UTMD-NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 53 BARD - NET SALES, 20132015 ($MILLION)
FIG. 54 BARD- NET SALES, SEGMENT, 2015 (%)
FIG. 55 BARD -NET SALES, GEOGRAPHY, 2015 (%)
FIG. 56 BD- NET SALES, 20132015($MILLION)
FIG. 57 BD-NET SALES, BY GEOGRAPHY, 2015(%)
FIG. 58 BD-NET SALES, BY SUB-SEGMENT, 2015(%)
FIG. 59 TELEFLEX- NET SALES, 2013-2015, ($MILLION)
FIG. 60 TELEFLEX- NET SALES, BY SEGMENT, 2015 (%)
FIG. 61 TELEFLEX-NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 62 BACTIGUARD-NET SALES, 2013-2015, ($MILLION)
FIG. 63 PATH-NET SALES, 2013-2015, ($MILLION)

List of Tables

TABLE 1 WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 2 WORLD NON PNEUMATIC ANTI SHOCK GARMENT DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 3 WORLD UNIJECT PREFILLED INJECTION SYSTEM DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 4 WORLD UTERINE BALLOON TAMPONADE DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 5 WORLD UTERINE BALLOON TAMPONADE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 6 WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 7 NORTH AMERICA: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 8 NORTH AMERICA: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 9 EUROPE: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 10 EUROPE: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 11 ASIA-PACIFIC: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 12 ASIA-PACIFIC: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 13 LAMEA: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 14 LAMEA: POSTPARTUM HEMORRHAGE DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 15 UTMD-COMPANY SNAPSHOT
TABLE 16 UTMD-OPERATING SEGMENTS
TABLE 17 BARD- COMPANY SNAPSHOT
TABLE 18 BARD OPERATING SEGMENTS
TABLE 19 COOK MEDICAL- COMPANY SNAPSHOT
TABLE 20 BD- COMPANY SNAPSHOT
TABLE 21 TELEFLEX- COMPANY SNAPSHOT
TABLE 22 TELEFLEX: OPERATING SEGMENTS
TABLE 23 BACTIGUARD: COMPANY SNAPSHOT
TABLE 24 BACTIGUARD- OPERATING SEGMENTS
TABLE 25 PATH - COMPANY SNAPSHOT
TABLE 26 PATH- OPERATING SEGMENTS
TABLE 27 3RD: COMPANY SNAPSHOT
TABLE 28 3RD: PRODUCT CATEGORIES
TABLE 29 INPRESS: COMPANY SNAPSHOT

PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT